CHICAGO, IL—When patients stop taking oral anticoagulation (OAC) after they’ve been free of atrial fibrillation (AF) ...
SAN DIEGO — Do patients with atrial fibrillation need oral anticoagulation (OAC) with a single antiplatelet therapy (APT) a year or more after receiving a coronary stent, or would OAC alone suffice? A ...
High-bleeding-risk (HBR) patients taking an oral anticoagulant (OAC), as well as those who were not, had similar rates of ischemic and net adverse events in the MASTER DAPT trial, no matter whether ...
In the OCEANIC-AF trial, asundexian resulted in a small increase in the rates of stroke and lowered bleeding compared with apixaban in patients with atrial fibrillation (AF) who were naive to oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results